出 处:《World Journal of Gastroenterology》2000年第6期824-828,共5页世界胃肠病学杂志(英文版)
摘 要:AIM To assess the effect of ACE inhibitor andAng Ⅱ type Ⅰ(AT1)receptor antagonist inpreventing hepatic fibrosis caused by CCl<sub>4</sub>administration in rats;to investigate whether ornot there are expression of AT 1 receptors onhepatic stellate cells;and to observe the effectof Ang Ⅱ on proliferation and ECM synthesis ofcultured HSCs.METHODS Studies were conducted in maleSprague-Dawley rats.Except for thehepatofibrotic model group and the controlgroup,in three treated groups,either enalapril(5 mg/kg),or Iosartan(10 mg/kg),or enalapril+Iosartan were given to the fibrotic rats bydaily gavage,and saline vehicle was given tomodel and normal control rats.After 6 weeks,liver fibrosis was assessed directly by hepaticmorphometric analysis,which has beenconsidered the gold standard for thequantification of fibrosis.The expressions of AT1 receptors and(α-mooth muscle actin,α-SMA)in liver tissue or isolated hepatic stellate cells(HSCs)were detected by immunohistochemicaltechniques.The effect of Ang Ⅱ on HSCproliferation was determined by MTT method.Effect of Ang Ⅱ on collagen synthesis of HSCswas determined by <sup>3</sup>H-proline incorporation.RESULTS Contrasted to the fibrosis in rats ofthe model group,groups of rats treated with either enalapril or Iosartan,or a combination oftwo drugs showed a limited expansion of theinterstitium(4.23±3.70 vs 11.22±4.79,P【0.05),but no difference was observedamong three treated groups(5.38±3.43,4.96±2.96,4.23±2.70,P】0.05).Expression of AT 1receptors was found in fibrotic interstitium offibrotic rats,whereas in normal control rats theywere limited to vasculature only to a very slightdegree.AT 1 receptors were also expressed onactivated HSCs in the culture.At concentrationsfrom 10<sup>-9</sup>to 10<sup>-5</sup>mol/L,Ang Ⅱ stimulated HSCproliferation in culture in a dose-dependentmanner.Increasing Ang Ⅱ concentrationsproduced corresponding increases in <sup>3</sup>H-prolineincorporation.Differences among groups were significant.CONCLAIM To assess the effect of ACE inhibitor and Ang Ⅱ type Ⅰ(AT1)receptor antagonist in preventing hepatic fibrosis caused by CCl_4 administration in rats;to investigate whether or not there are expression of AT 1 receptors on hepatic stellate cells;and to observe the effect of Ang Ⅱ on proliferation and ECM synthesis of cultured HSCs. METHODS Studies were conducted in male Sprague-Dawley rats.Except for the hepatofibrotic model group and the control group,in three treated groups,either enalapril (5 mg/kg),or Iosartan(10 mg/kg),or enalapril +Iosartan were given to the fibrotic rats by daily gavage,and saline vehicle was given to model and normal control rats.After 6 weeks, liver fibrosis was assessed directly by hepatic morphometric analysis,which has been considered the gold standard for the quantification of fibrosis.The expressions of AT 1 receptors and(α-mooth muscle actin,α-SMA) in liver tissue or isolated hepatic stellate cells (HSCs)were detected by immunohistochemical techniques.The effect of Ang Ⅱ on HSC proliferation was determined by MTT method. Effect of Ang Ⅱ on collagen synthesis of HSCs was determined by ~3H-proline incorporation. RESULTS Contrasted to the fibrosis in rats of the model group,groups of rats treated with either enalapril or Iosartan,or a combination of two drugs showed a limited expansion of the interstitium(4.23±3.70 vs 11.22±4.79, P<0.05),but no difference was observed among three treated groups(5.38±3.43,4.96± 2.96,4.23±2.70,P>0.05).Expression of AT 1 receptors was found in fibrotic interstitium of fibrotic rats,whereas in normal control rats they were limited to vasculature only to a very slight degree.AT 1 receptors were also expressed on activated HSCs in the culture.At concentrations from 10^(-9)to 10^(-5)mol/L,Ang Ⅱ stimulated HSC proliferation in culture in a dose-dependent manner.Increasing Ang Ⅱ concentrations produced corresponding increases in ~3H-proline incorporation.Differences among groups were significant.CONCLUSION Angiotensin-converting enzyme i
关 键 词:RENIN-ANGIOTENSIN system LIVER cirrhosis ENALAPRIL extracellular matrix immunohistochemistry LOSARTAN liver/injuries
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...